Ambry Genetics’ CARE programme validated for accuracy in identifying patients for hereditary cancer testing: Aliso Viejo, California Saturday, June 28, 2025, 18:00 Hrs [IST] Amb ...

Biodexa Pharma activates first clinical study site for phase 3 Serenta trial in familial adenomatous polyposis: United Kingdom Saturday, June 28, 2025, 15:00 Hrs [IST] Biodexa Pha ...

Icon Group and Varian expand partnership to deliver advanced cancer technology across the United Kingdom: London Saturday, June 28, 2025, 16:00 Hrs [IST] Icon Group, a global lead ...

Applied StemCell releases hiEX Research iPSC Exosomes to explore next-generation regenerative medicine research: Milpitas, California Saturday, June 28, 2025, 17:00 Hrs [IST] Appl ...

KalVista Pharma inks licensing agreement with Pendopharm to commercialize sebetralstat for HAE in Canada: Cambridge, Massachusetts Saturday, June 28, 2025, 14:00 Hrs [IST] KalVist ...

US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma: Princeton, New Jersey Saturday, June 28, 20 ...

WHO is alerting health-care professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicines—Ozempic, ...

European Commission approves Eylea 8 mg with extended 6-month treatment interval for nAMD and visual impairment due to DME: Berlin Saturday, June 28, 2025, 09:00 Hrs [IST] The Eur ...

Bavarian Nordic initiates clinical trials of mpox vaccine in infants and pregnant women: Copenhagen, Denmark Saturday, June 28, 2025, 12:00 Hrs [IST] Bavarian Nordic A/S, a global ...

Centre makes application for WHO GMP & COPP mandatory through ONLDS portal from July 15: Gireesh Babu, New Delhi Saturday, June 28, 2025, 08:00 Hrs [IST] The Central drug regulato ...

India’s digital health propels new era of integration and innovation: Nandita Vijayasimha, Bengaluru Saturday, June 28, 2025, 08:00 Hrs [IST] India’s digital health ecosystem ...

Indian pharma speeds up access to global therapies while targeting treatment gaps: Nandita Vijayasimha, Bengaluru Saturday, June 28, 2025, 08:00 Hrs [IST] Indian pharma is now agg ...